As I’ve posted about before, Sanofi and Genzyme are merging. This deal has taken awhile, and is structured as a tender offer. It’s for $74 per share in cash, but also comes with a contingent value right that will be valuable if certain Genzyme drugs make it to market. Interesting deal. Shareholders wishing to tender […]